Page last updated: 2024-10-22

aminoglutethimide and Diabetic Neuropathies

aminoglutethimide has been researched along with Diabetic Neuropathies in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Low, P1
Kihara, M1
Cameron, N1
Cotter, M1
Poduslo, J1

Reviews

1 review available for aminoglutethimide and Diabetic Neuropathies

ArticleYear
Cause and effect of ischaemia in chronic experimental diabetic neuropathy.
    Diabetic medicine : a journal of the British Diabetic Association, 1993, Volume: 10 Suppl 2

    Topics: Aminoglutethimide; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ischemia; Periph

1993